glp 1 addiction studies GLP-1 receptor agonists show promise in treating substance use disorders Mechanisms of GLP-1 in Modulating

Pro-inflammatory cytokines, including interferon- and TNF-, play a role in the initial response and amplification of the inflammatory reaction ( L.reuteri LR1 has demonstrated the ability to reduce the gene expression of IL-1, TNF-, and IFN-, lower the protein levels of IL-6 and TNF-, and increase TGF- expression ( L.reuteri supplementation led to elevated levels of IgG and anti-inflammatory cytokines (IL-4, IL-10, TGF-) while decreasing pro-inflammatory cytokines (IL-1, IL-6, TNF - ) in both serum and ileal mucosa

Its neuroprotective potential is another exciting facet, as it may safeguard neurons from oxidative damage, offering hope for interventions in neurodegenerative disorders

GLP-1 medications are also now being studied in individuals with metabolic liver disease, peripheral artery disease and neurodegenerative disorders, such as Alzheimers disease and Parkinsons disease

J Am Heart Assoc 9(16):e016334

You may click here to check if citations are available, but are not listed here yet

doi: 10.1111/j.1532-950x.2003.00515.x